Amarin (NASDAQ:AMRN – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, March 12th. Analysts expect Amarin to post earnings of ($0.06) per ...

Operator Welcome to Amarin Corporation's conference call to discuss its fourth-quarter and full-year 2024 business update and ...

Leading up to and during those negotiations, you'll likely hear the terms "salary cap" and "cap space" used by analysts to describe whether or not teams are in the running for specific players.

And Steve Ketchum, Amarin's Executive Vice President, President of R&D and Chief Scientific Officer will provide an update on recent and upcoming VASCEPA/VAZKEPA research. And at the end of the ...

Indian mid-and small-cap stocks are at the forefront of the sustained market sell-off as investors continued to withdraw billions of rupees from these segments, leaving once-favoured pockets of ...

IPE, which is the active ingredient in vascepa, significantly reduced the primary composite endpoint of cardiovascular events by 34% among patients with very well-controlled LDL-C. Elevated LDL-C ...

The NBA and NHL salary caps are fairly straight forward — contracts are fully guaranteed, and every dollar earned counts that year against the cap. But guaranteed contracts are the exception in ...

mainly due to pricing pressure from U.S. generics targeting its heart disease therapy Vascepa/Vazkepa. As for the bottom line, AMRN reported an adjusted basic and diluted loss per share of $0.02 ...